4.4 Article

Non-Specific, Functional, and Somatoform Bodily Complaints

Journal

DEUTSCHES ARZTEBLATT INTERNATIONAL
Volume 109, Issue 47, Pages 803-U46

Publisher

DEUTSCHER AERZTE-VERLAG GMBH
DOI: 10.3238/arztebl.2012.0803

Keywords

-

Funding

  1. Lilly
  2. Falk Foundation
  3. Janssen-Cilag

Ask authors/readers for more resources

Background: 4-10% of the general population and 20% of primary care patients have what are called non-specific, functional, and somatoform bodily complaints. These often take a chronic course, markedly impair the sufferers' quality of life, and give rise to high costs. They can be made worse by inappropriate behavior on the physician's part. Methods: The new S3 guideline was formulated by representatives of 29 medical and psychological specialty societies and one patient representative. They analyzed more than 4000 publications retrieved by a systematic literature search and held two online Delphi rounds and three consensus conferences. Results: Because of the breadth of the topic, the available evidence varied in quality depending on the particular subject addressed and was often only of moderate quality. A strong consensus was reached on most subjects. In the new guideline, it is recommended that physicians should establish a therapeutic alliance with the patient, adopt a symptom/coping-oriented attitude, and avoid stigmatizing comments. A biopsychosocial diagnostic evaluation, combined with sensitive discussion of signs of psychosocial stress, enables the early recognition of problems of this type, as well as of comorbid conditions, while lowering the risk of iatrogenic somatization. For mild, uncomplicated courses, the establishment of a biopsychosocial explanatory model and physical/social activation are recommended. More severe, complicated courses call for collaborative, coordinated management, including regular appointments (as opposed to ad-hoc appointments whenever the patient feels worse), graded activation, and psychotherapy; the latter may involve cognitive behavioral therapy or a psychodynamic-interpersonal or hypnotherapeutic/imaginative approach. The comprehensive treatment plan may be multimodal, potentially including body-oriented/non-verbal therapies, relaxation training, and time-limited pharmacotherapy. Conclusion: A thorough, simultaneous biopsychosocial diagnostic assessment enables the early recognition of non-specific, functional, and somatoform bodily complaints. The appropriate treatment depends on the severity of the condition. Effective treatment requires the patient's active cooperation and the collaboration of all treating health professionals under the overall management of the patient's primary-care physician. Cite this as: Schaefert R, Hausteiner-Wiehle C, Huser W, Ronel J, Herrmann M, Henningsen P: Clinical Practice Guideline: Non-specific, functional and somatoform bodily complaints. Dtsch Arztebl Int 2012; 109(47): 803-13. DOI: 10.3238/arztebl.2012.0803

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ethics

Association of medical futility with do-not-resuscitate (DNR) code status in hospitalised patients

Christoph Becker, Alessandra Manzelli, Alexander Marti, Hasret Cam, Katharina Beck, Alessia Vincent, Annalena Keller, Stefano Bassetti, Daniel Rikli, Rainer Schaefert, Kai Tisljar, Raoul Sutter, Sabina Hunziker

Summary: The study found a high prevalence of DNR code status among inpatients at the University Hospital of Basel, with a significant proportion of patients choosing full code status despite CPR being considered futile. Presumed CPR futility was closely associated with the decision to refuse resuscitation attempts.

JOURNAL OF MEDICAL ETHICS (2021)

Article Gastroenterology & Hepatology

The Validity of Somatic Symptom Disorder in Patients With Gastrointestinal Complaints

Sabrina Berens, Rainer Schaefert, Johannes C. Ehrenthal, David Baumeister, Annika Gauss, Wolfgang Eich, Jonas Tesarz

Summary: The study compared patients with chronic gastrointestinal complaints with and without somatic symptom disorder (SSD) and found that patients with SSD had higher gastrointestinal pain severity, health and work-related impairment, psychological distress, mentalizing, and personality functioning deficits compared to those without SSD. The results suggest that SSD may be a valid identifier of patients with high psychological burden independent of the medical cause of their symptoms.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)

Article Psychiatry

Psychological burden in patients with COVID-19 and their relatives 90 days after hospitalization: A prospective observational cohort study

Alessia Vincent, Katharina Beck, Christoph Becker, Samuel Zumbrunn, Maja Ramin-Wright, Tabita Urben, Adrian Quinto, Rainer Schaefert, Gunther Meinlschmidt, Jens Gaab, Thomas Reinhardt, Stefano Bassetti, Philipp Schuetz, Sabina Hunziker

Summary: COVID-19 is associated with clinically relevant psychological distress in a subgroup of patients and their relatives 90 days after hospital discharge. Understanding potential risk and protective factors may help in developing preventive strategies for this population.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2021)

Article Multidisciplinary Sciences

Prevalence and factors associated with psychological burden in COVID-19 patients and their relatives: A prospective observational cohort study

Katharina Beck, Alessia Vincent, Christoph Becker, Annalena Keller, Hasret Cam, Rainer Schaefert, Thomas Reinhardt, Raoul Sutter, Kai Tisljar, Stefano Bassetti, Philipp Schuetz, Sabina Hunziker

Summary: The study found that a significant number of COVID-19 patients and their relatives experienced psychological distress 30 days after hospital discharge, with factors such as resilience, perceived stress levels, and frequency of contact with relatives being associated with distress. These findings may help in developing strategies to prevent psychological distress in COVID-19 patients and their relatives.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Pain and psyche in a patient with irritable bowel syndrome: chicken or egg? A time series case report

Felicitas Engel, Tatjana Stadnitski, Esther Stroe-Kunold, Sabrina Berens, Rainer Schaefert, Beate Wild

Summary: This study found a high correlation between somatic symptoms preceding psychological variables in time, and using positive thoughts as a coping strategy was helpful in reducing pain for the patient with irritable bowel syndrome.

BMC GASTROENTEROLOGY (2021)

Article Cell Biology

The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome

Sandra Mohr, Nikola Fritz, Christian Hammer, Cristina Martinez, Sabrina Berens, Stefanie Schmitteckert, Verena Wahl, Malin Schmidt, Lesley A. Houghton, Miriam Goebel-Stengel, Maria Kabisch, Dorothea Gotze, Irina Milovac, Mauro D'Amato, Tenghao Zheng, Ralph Roth, Hubert Monnikes, Felicitas Engel, Annika Gauss, Jonas Tesarz, Martin Raithel, Viola Andresen, Thomas Frieling, Jutta Keller, Christian Pehl, Christoph Stein-Thoringer, Gerard Clarke, Paul J. Kennedy, John F. Cryan, Timothy G. Dinan, Eamonn M. M. Quigley, Robin Spiller, Caroll Beltran, Ana Maria Madrid, Veronica Torres, Edith Perez de Arce, Wolfgang Herzog, Emeran A. Mayer, Gregory Sayuk, Maria Gazouli, George Karamanolis, Lejla Kapur-Pojskic, Mariona Bustamante, Raquel Rabionet, Xavier Estivil, Andre Franke, Wolfgang Lieb, Guy Boeckxstaens, Mira M. Wouters, Magnus Simren, Gudrun A. Rappold, Maria Vicario, Javier Santos, Rainer Schaefert, Justo Lorenzo-Bermejo, Beate Niesler

Summary: This study identified genetic single nucleotide polymorphisms (SNPs) associated with irritable bowel syndrome (IBS), particularly with constipation-predominant IBS (IBS-C) in females. Validation in patients and controls from eight countries confirmed the association of the tagging SNP rs2020938 with female IBS-C. Further experiments demonstrated the functional relevance of rs2020938 in differential SLC6A4 expression in the jejunum and stool consistency.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Psychology, Multidisciplinary

Higher Levels of Psychological Burden and Alterations in Personality Functioning in Crohn's Disease and Ulcerative Colitis

Felicitas Engel, Sabrina Berens, Annika Gauss, Rainer Schaefert, Wolfgang Eich, Jonas Tesarz

Summary: The study found that patients with CD/UC have higher levels of depression and anxiety compared to HC, and there are differences in personality functioning in the domain of self-perception and regulation. Minor differences were found in mentalization and attachment between CD/UC and HC.

FRONTIERS IN PSYCHOLOGY (2021)

Review Clinical Neurology

Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain

Frank Petzke, Thomas Toelle, Mary-Ann Fitzcharles, Winfried Haeuser

Summary: Neuropathic pain is a challenging condition with current medications providing inadequate relief, leading to the consideration of cannabis-based medicines as a treatment option. However, the evidence supporting the use of cannabis-based medicines for chronic neuropathic pain is of low quality, with conflicting conclusions on their efficacy and potential side effects, indicating the need for further research.

CNS DRUGS (2022)

Review Pharmacology & Pharmacy

Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain

Mary-Ann Fitzcharles, Frank Petzke, Thomas R. Toelle, Winfried Hauser

Summary: Nociplastic pain is characterized by sensitization of the nervous system without a clear anatomical abnormality to explain the pain severity. It is often associated with central nervous system symptoms such as fatigue, cognitive difficulties, and sleep disturbances, as well as other somatic symptoms. The use of cannabinoids, including cannabis-based medicines, for treating nociplastic pain conditions is a potential avenue that warrants further investigation and understanding by healthcare providers.

DRUGS (2021)

Editorial Material Anesthesiology

Register-based studies on cannabis-based medicines and medical cannabis need reliable diagnoses and cannabis treatment details COMMENT

Winfried Haeuser, Mary-Ann Fitzcharles

EUROPEAN JOURNAL OF PAIN (2022)

Review Anesthesiology

Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety

Patric Bialas, Mary-Ann Fitzcharles, Petra Klose, Winfried Haeuser

Summary: This systematic review evaluated the effectiveness, tolerability, and safety of cannabis-based medicines (CbMs) for chronic non-cancer pain (CNCP) in long-term observational studies. The results showed that CbMs had positive effects on multiple symptoms for some CNCP patients and were generally well tolerated and safe. However, the certainty of evidence in observational studies was very low.

EUROPEAN JOURNAL OF PAIN (2022)

Article Anesthesiology

Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres

Patric Bialas, Claudia Boettge-Wolpers, Mary-Ann Fitzcharles, Sven Gottschling, Dieter Konietzke, Stephanie Juckenhoefel, Albrecht Madlinger, Patrick Welsch, Winfried Haeuser

Summary: There are concerns about the development of cannabis use disorder (CUD) in patients using medical cannabis for chronic pain. The current diagnostic criteria for CUD may not accurately identify patients using cannabis for therapeutic reasons. Alternative strategies are needed to determine the true prevalence of CUD in chronic pain patients treated with medical cannabis. In a study conducted in three German pain centers, the prevalence of CUD in chronic pain patients prescribed medical cannabis was assessed using anonymous questionnaires.
Article Rheumatology

Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia

Ana Margarida Pinto, Rinie Geenen, Tor D. Wager, Mark A. Lumley, Winfried Hauser, Eva Kosek, Jacob N. Ablin, Kirstine Amris, Jaime Branco, Dan Buskila, Joao Castelhano, Miguel Castelo-Branco, Leslie J. Crofford, Mary-Ann Fitzcharles, Marina Lopez-Sola, Mariana Luis, Tiago Reis Marques, Philip J. Mease, Filipe Palavra, Jamie L. Rhudy, Lucina Q. Uddin, Paula Castilho, Johannes W. G. Jacobs, Jose A. P. da Silva

Summary: This article presents a new model called FITSS (Fibromyalgia: Imbalance of Threat and Soothing Systems), which proposes that an imbalance in emotion regulation, specifically an overactive 'threat' system and underactive 'soothing' system, may contribute to the development of fibromyalgia. This model provides a new perspective for future research and may stimulate the discovery of novel therapeutic interventions.

NATURE REVIEWS RHEUMATOLOGY (2023)

Article Psychiatry

Depressive symptoms, but not anxiety, predict subsequent diagnosis of Coronavirus disease 19: a national cohort study

G. Meinlschmidt, S. Guemghar, N. Roemmel, E. Battegay, S. Hunziker, R. Schaefert

Summary: The study found that depressive symptoms were associated with an increased risk of COVID-19 diagnosis, while anxiety symptoms did not predict COVID-19. Depressive symptoms predicted the likelihood of being tested for SARS-CoV-2, but did not predict COVID-19 in those tested.

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2022)

Article Psychology, Multidisciplinary

Different Dimensions of Affective Processing in Patients With Irritable Bowel Syndrome: A Multi-Center Cross-Sectional Study

Sabrina Berens, Rainer Schaefert, Johannes C. Ehrenthal, David Baumeister, Wolfgang Eich, Jonas Tesarz

Summary: Deficits in affective processing were found in patients with Irritable Bowel Syndrome (IBS) compared to healthy controls (HCs) across six different dimensions, with the most pronounced deficits in affect tolerance. Affective processing in IBS was significantly influenced by anxiety levels and insecure attachment styles, highlighting potential targets for specific psychotherapeutic interventions.

FRONTIERS IN PSYCHOLOGY (2021)

No Data Available